Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 140-152 |
| Number of pages | 13 |
| Journal | European Journal of Cancer |
| Volume | 77 |
| DOIs | |
| Publication status | Published - 2017 |
Fingerprint
Keywords
- Cancer registries
- EUROCARE
- Europe
- Papillary
- Relative survival
- Thyroid cancer
- adult
- age
- Article
- cancer diagnosis
- cancer incidence
- cancer mortality
- cancer registry
- cancer survival
- cohort analysis
- Croatia
- female
- France
- human
- Ireland
- major clinical study
- male
- mortality rate
- Northern European
- oncological parameters
- priority journal
- relative survival
- sex
- Southern Europe
- survival rate
- survival time
- thyroid cancer
- thyroid papillary carcinoma
- adenocarcinoma
- adolescent
- aged
- carcinoma
- clinical trial
- demography
- diagnosis related group
- epidemiology
- incidence
- middle aged
- mortality
- multicenter study
- register
- sex ratio
- statistics and numerical data
- thyroid tumor
- young adult
- Adenocarcinoma, Follicular
- Adolescent
- Adult
- Aged
- Carcinoma
- Diagnosis-Related Groups
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Registries
- Residence Characteristics
- Sex Distribution
- Thyroid Neoplasms
- Young Adult
Cite this
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. / Dal Maso, L.; Tavilla, A.; Pacini, F.; Serraino, D.; van Dijk, B.A.C.; Chirlaque, M.D.; Capocaccia, R.; Larrañaga, N.; Colonna, M.; Agius, D.; Ardanaz, E.; Rubió-Casadevall, J.; Kowalska, A.; Virdone, S.; Mallone, S.; Amash, H.; De Angelis, R.; Hackl, M.; Zielonke, N.; Van Eycken, E.; Henau, K.; Valerianova, Z.; Dimitrova, N.; Sekerija, M.; Dušek, L.; Zvolský, M.; Storm, H.; Engholm, G.; Mägi, M.; Aareleid, T.; Malila, N.; Seppä, K.; Velten, M.; Guizard, A.V.; Faivre, J.; Woronoff, A.S.; Tretarre, B.; Bossard, N.; Uhry, Z.; Molinié, F.; Bara, S.; Schvartz, C.; Lapôtre-Ledoux, B.; Grosclaude, P.; Stabenow, R.; Luttmann, S.; Eberle, A.; Brenner, H.; Nennecke, A.; Engel, J.; Schubert-Fritschle, G.; Heidrich, J.; Holleczek, B.; Katalinic, A.; Jónasson, J.G.; Tryggvadóttir, L.; Comber, H.; Mazzoleni, G.; Bulatko, A.; Buzzoni, C.; Giacomin, A.; Sutera Sardo, A.; Mazzei, A.; Ferretti, S.; Barchielli, A.; Caldarella, A.; Gatta, G.; Sant, M.; Amati, C.; Baili, P.; Berrino, F.; Bonfarnuzzo, S.; Botta, L.; Di Salvo, F.; Foschi, R.; Margutti, C.; Meneghini, E.; Minicozzi, P.; Trama, A.; Zucchetto, A.; Caldora, M.; Carrani, E.; Francisci, S.; Pierannunzio, D.; Roazzi, P.; Rossi, S.; Santaquilani, M.; Pannozzo, F.; Busco, S.; Filiberti, R.A.; Vercelli, M.; Ricci, P.; Autelitano, M.; Spagnoli, G.; Cirilli, C.; Fusco, M.; Vitale, M.F.; Usala, M.; Vitale, F.; Ravazzolo, B.; Michiara, M.; Tumino, R.; Mangone, L.; Vicentini, M.; Falcini, F.; Iannelli, A.; Sechi, O.; Cesaraccio, R.; Piffer, S.; Madeddu, A.; Tisano, F.; Maspero, S.; Fanetti, A.C.; Zanetti, R.; Rosso, S.; Candela, P.; Scuderi, T.; Stracci, F.; Rocca, A.; Tagliabue, G.; Contiero, P.; Rugge, M.; Tognazzo, S.; Pildava, S.; Smailyte, G.; Calleja, N.; Johannesen, T.B.; Rachtan, J.; Góźdź, S.; Mężyk, R.; Błaszczyk, J.; Bębenek, M.; Bielska-Lasota, M.; Forjaz de Lacerda, G.; Bento, M.J.; Castro, C.; Miranda, A.; Mayer-da-Silva, A.; Safaei Diba, C.; Primic-Zakelj, M.; Errezola, M.; Bidaurrazaga, J.; Díaz García, J.M.; Marcos-Navarro, A.I.; Marcos-Gragera, R.; Izquierdo Font, A.; Sanchez, M.J.; Molina, E.; Navarro, C.; Moreno-Iribas, C.; Galceran, J.; Carulla, M.; Lambe, M.; Khan, S.; Mousavi, M.; Bouchardy, C.; Usel, M.; Ess, S.M.; Frick, H.; Lorez, M.; Herrmann, C.; Bordoni, A.; Spitale, A.; Konzelmann, I.; Visser, O.; Ho, V.; Otter, R.; Coleman, M.; Allemani, C.; Rachet, B.; Rashbass, J.; Broggio, J.; Verne, J.; Gavin, A.; Donnelly, C.; Brewster, D.H.; Huws, D.W.; White, C.
In: European Journal of Cancer, Vol. 77, 2017, p. 140-152.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
AU - Dal Maso, L.
AU - Tavilla, A.
AU - Pacini, F.
AU - Serraino, D.
AU - van Dijk, B.A.C.
AU - Chirlaque, M.D.
AU - Capocaccia, R.
AU - Larrañaga, N.
AU - Colonna, M.
AU - Agius, D.
AU - Ardanaz, E.
AU - Rubió-Casadevall, J.
AU - Kowalska, A.
AU - Virdone, S.
AU - Mallone, S.
AU - Amash, H.
AU - De Angelis, R.
AU - Hackl, M.
AU - Zielonke, N.
AU - Van Eycken, E.
AU - Henau, K.
AU - Valerianova, Z.
AU - Dimitrova, N.
AU - Sekerija, M.
AU - Dušek, L.
AU - Zvolský, M.
AU - Storm, H.
AU - Engholm, G.
AU - Mägi, M.
AU - Aareleid, T.
AU - Malila, N.
AU - Seppä, K.
AU - Velten, M.
AU - Guizard, A.V.
AU - Faivre, J.
AU - Woronoff, A.S.
AU - Tretarre, B.
AU - Bossard, N.
AU - Uhry, Z.
AU - Molinié, F.
AU - Bara, S.
AU - Schvartz, C.
AU - Lapôtre-Ledoux, B.
AU - Grosclaude, P.
AU - Stabenow, R.
AU - Luttmann, S.
AU - Eberle, A.
AU - Brenner, H.
AU - Nennecke, A.
AU - Engel, J.
AU - Schubert-Fritschle, G.
AU - Heidrich, J.
AU - Holleczek, B.
AU - Katalinic, A.
AU - Jónasson, J.G.
AU - Tryggvadóttir, L.
AU - Comber, H.
AU - Mazzoleni, G.
AU - Bulatko, A.
AU - Buzzoni, C.
AU - Giacomin, A.
AU - Sutera Sardo, A.
AU - Mazzei, A.
AU - Ferretti, S.
AU - Barchielli, A.
AU - Caldarella, A.
AU - Gatta, G.
AU - Sant, M.
AU - Amati, C.
AU - Baili, P.
AU - Berrino, F.
AU - Bonfarnuzzo, S.
AU - Botta, L.
AU - Di Salvo, F.
AU - Foschi, R.
AU - Margutti, C.
AU - Meneghini, E.
AU - Minicozzi, P.
AU - Trama, A.
AU - Zucchetto, A.
AU - Caldora, M.
AU - Carrani, E.
AU - Francisci, S.
AU - Pierannunzio, D.
AU - Roazzi, P.
AU - Rossi, S.
AU - Santaquilani, M.
AU - Pannozzo, F.
AU - Busco, S.
AU - Filiberti, R.A.
AU - Vercelli, M.
AU - Ricci, P.
AU - Autelitano, M.
AU - Spagnoli, G.
AU - Cirilli, C.
AU - Fusco, M.
AU - Vitale, M.F.
AU - Usala, M.
AU - Vitale, F.
AU - Ravazzolo, B.
AU - Michiara, M.
AU - Tumino, R.
AU - Mangone, L.
AU - Vicentini, M.
AU - Falcini, F.
AU - Iannelli, A.
AU - Sechi, O.
AU - Cesaraccio, R.
AU - Piffer, S.
AU - Madeddu, A.
AU - Tisano, F.
AU - Maspero, S.
AU - Fanetti, A.C.
AU - Zanetti, R.
AU - Rosso, S.
AU - Candela, P.
AU - Scuderi, T.
AU - Stracci, F.
AU - Rocca, A.
AU - Tagliabue, G.
AU - Contiero, P.
AU - Rugge, M.
AU - Tognazzo, S.
AU - Pildava, S.
AU - Smailyte, G.
AU - Calleja, N.
AU - Johannesen, T.B.
AU - Rachtan, J.
AU - Góźdź, S.
AU - Mężyk, R.
AU - Błaszczyk, J.
AU - Bębenek, M.
AU - Bielska-Lasota, M.
AU - Forjaz de Lacerda, G.
AU - Bento, M.J.
AU - Castro, C.
AU - Miranda, A.
AU - Mayer-da-Silva, A.
AU - Safaei Diba, C.
AU - Primic-Zakelj, M.
AU - Errezola, M.
AU - Bidaurrazaga, J.
AU - Díaz García, J.M.
AU - Marcos-Navarro, A.I.
AU - Marcos-Gragera, R.
AU - Izquierdo Font, A.
AU - Sanchez, M.J.
AU - Molina, E.
AU - Navarro, C.
AU - Moreno-Iribas, C.
AU - Galceran, J.
AU - Carulla, M.
AU - Lambe, M.
AU - Khan, S.
AU - Mousavi, M.
AU - Bouchardy, C.
AU - Usel, M.
AU - Ess, S.M.
AU - Frick, H.
AU - Lorez, M.
AU - Herrmann, C.
AU - Bordoni, A.
AU - Spitale, A.
AU - Konzelmann, I.
AU - Visser, O.
AU - Ho, V.
AU - Otter, R.
AU - Coleman, M.
AU - Allemani, C.
AU - Rachet, B.
AU - Rashbass, J.
AU - Broggio, J.
AU - Verne, J.
AU - Gavin, A.
AU - Donnelly, C.
AU - Brewster, D.H.
AU - Huws, D.W.
AU - White, C.
N1 - Cited By :3 Export Date: 20 February 2018 CODEN: EJCAE Correspondence Address: Dal Maso, L.; Cancer Epidemiology Unit, CRO Aviano National Cancer Institute IRCCS, Via Franco Gallini 2, Italy; email: epidemiology@cro.it
PY - 2017
Y1 - 2017
N2 - Background Incidence rates of thyroid cancer (TC) increased in several countries during the last 30 years, while mortality rates remained unchanged, raising important questions for treatment and follow-up of TC patients. This study updates population-based estimates of relative survival (RS) after TC diagnosis in Europe by sex, country, age, period and histology. Methods Data from 87 cancer registries in 29 countries were extracted from the EUROCARE-5 dataset. One- and 5-year RS were estimated using the cohort approach for 86,690 adult TC patients diagnosed in 2000–2007 and followed-up to 12/31/2008. RS trends in 1999–2007 and 10-year RS in 2005–2007 were estimated using the period approach. Results In Europe 2000–2007, 5-year RS after TC was 88% in women and 81% in men. Survival rates varied by country and were strongly correlated (Pearson ρ = 75%) with country-specific incidence rates. Five-year RS decreased with age (in women from >95% at age 15–54 to 57% at age 75+), from 98% in women and 94% in men with papillary TC to 14% in women and 12% in men with anaplastic TC. Proportion of papillary TC varied by country and increased over time, while survival rates were similar across areas and periods. In 1999–2007, 5-year RS increased by five percentage points for all TCs but only by two for papillary and by four for follicular TC. Ten-year RS in 2005–2007 was 89% in women and 79% in men. Conclusions The reported increasing TC survival trend and differences by area are mainly explained by the varying histological case-mix of cases. © 2017 Elsevier Ltd
AB - Background Incidence rates of thyroid cancer (TC) increased in several countries during the last 30 years, while mortality rates remained unchanged, raising important questions for treatment and follow-up of TC patients. This study updates population-based estimates of relative survival (RS) after TC diagnosis in Europe by sex, country, age, period and histology. Methods Data from 87 cancer registries in 29 countries were extracted from the EUROCARE-5 dataset. One- and 5-year RS were estimated using the cohort approach for 86,690 adult TC patients diagnosed in 2000–2007 and followed-up to 12/31/2008. RS trends in 1999–2007 and 10-year RS in 2005–2007 were estimated using the period approach. Results In Europe 2000–2007, 5-year RS after TC was 88% in women and 81% in men. Survival rates varied by country and were strongly correlated (Pearson ρ = 75%) with country-specific incidence rates. Five-year RS decreased with age (in women from >95% at age 15–54 to 57% at age 75+), from 98% in women and 94% in men with papillary TC to 14% in women and 12% in men with anaplastic TC. Proportion of papillary TC varied by country and increased over time, while survival rates were similar across areas and periods. In 1999–2007, 5-year RS increased by five percentage points for all TCs but only by two for papillary and by four for follicular TC. Ten-year RS in 2005–2007 was 89% in women and 79% in men. Conclusions The reported increasing TC survival trend and differences by area are mainly explained by the varying histological case-mix of cases. © 2017 Elsevier Ltd
KW - Cancer registries
KW - EUROCARE
KW - Europe
KW - Papillary
KW - Relative survival
KW - Thyroid cancer
KW - adult
KW - age
KW - Article
KW - cancer diagnosis
KW - cancer incidence
KW - cancer mortality
KW - cancer registry
KW - cancer survival
KW - cohort analysis
KW - Croatia
KW - female
KW - France
KW - human
KW - Ireland
KW - major clinical study
KW - male
KW - mortality rate
KW - Northern European
KW - oncological parameters
KW - priority journal
KW - relative survival
KW - sex
KW - Southern Europe
KW - survival rate
KW - survival time
KW - thyroid cancer
KW - thyroid papillary carcinoma
KW - adenocarcinoma
KW - adolescent
KW - aged
KW - carcinoma
KW - clinical trial
KW - demography
KW - diagnosis related group
KW - epidemiology
KW - incidence
KW - middle aged
KW - mortality
KW - multicenter study
KW - register
KW - sex ratio
KW - statistics and numerical data
KW - thyroid tumor
KW - young adult
KW - Adenocarcinoma, Follicular
KW - Adolescent
KW - Adult
KW - Aged
KW - Carcinoma
KW - Diagnosis-Related Groups
KW - Female
KW - Humans
KW - Incidence
KW - Male
KW - Middle Aged
KW - Registries
KW - Residence Characteristics
KW - Sex Distribution
KW - Thyroid Neoplasms
KW - Young Adult
U2 - 10.1016/j.ejca.2017.02.023
DO - 10.1016/j.ejca.2017.02.023
M3 - Article
VL - 77
SP - 140
EP - 152
JO - European Journal of Cancer
JF - European Journal of Cancer
SN - 0959-8049
ER -